$HYFM Cashflow Statement | Understand Stock

$HYFM

$0.83 +$0.04 (4.56%) Close

$HYFM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, depletion and amortization
Provision for credit losses
Provision for inventory obsolescence
Non-cash restructuring expenses
Restructuring expenses
Impairments
Interest expense capitalized to principal of long-term debt
Change in fair value of contingent consideration
Payment of interest capitalized to principal of long-term debt
Deferred income tax expense (benefit)
Stock-based compensation expense
Non-cash operating lease expense
Non-cash loss from asset disposition
Other
Changes in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Lease liabilities
Other long-term liabilities

Net cash used in operating activities
Investing activities
Business combinations, net of cash and cash equivalents
Capital expenditures of property, plant and equipment
Issuance of notes receivable
Proceeds from notes receivable
Proceeds from sale of property, plant and equipment
Cash proceeds from IGE Asset Sale for property, plant and equipment
Other
Net cash (used in) from investing activities

Financing activities
Proceeds from issuance of common stock upon follow-on public offering, net of offering costs
Proceeds from exercises of investor warrants
Proceeds from Sale-Leaseback Transaction
Payment of withholding tax related to stock awards
Proceeds from issuance of common stock upon initial public offering, net of offering costs
Proceeds from issuance of Series A Convertible Preferred Stock, net of issuance costs
Payments of Series A Preferred stock cumulative dividend upon initial public offering
Borrowings from PPP Loan
Borrowings under foreign revolving credit facilities
Repayments of foreign revolving credit facilities
Repayments of Term Loan
Proceeds from issuance of Term Loan, net of discount and issuance costs
Payments to settle contingent consideration
Other
Financing cash flows from finance leases
Finance lease principal payments
Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents cash at beginning of year
Cash and cash equivalents at end of year
Non-cash investing and financing activities
Issuance of common stock as consideration in connection with business combinations
Increase in accrued expenses and other current liabilities for contingent consideration
Right-of-use assets acquired under operating lease obligation
Conversion of Series A Convertible Preferred Stock to common stock
Shares repurchased for withholding tax on restricted stock units
Issuance of Series A Convertible Preferred Stock upon conversion of debt and accrued interest
Receivable related to issuance of Series A Convertible Preferred Stock
Right-of-use assets (relinquished) acquired under operating lease obligation
Right-of-use assets acquired (relinquished) under operating lease obligation
Assets acquired under finance lease obligation
Capital expenditures included in accounts payable and accrued liabilities
Additions of leasehold improvements and related asset retirement obligations

Supplemental information
Cash paid for interest
Cash paid for income taxes

Comments